Apoplexy in sellar metastasis is very rare with only a few case reports in literature. A case of apoplexy in sellar metastasis from follicular thyroid carcinoma is reported and the literature is briefly reviewed. The patient presented with sudden onset headache and bi-lateral loss of vision following thyroidectomy in a case of follicular carcinoma thyroid with proven sellar metastasis. CT scan showed hyperdense blood in sellar mass suggestive of apoplexy in sellar metastasis. The patient underwent early trans-sphenoidal decompression. Apoplexy in sellar metastasis, although very rare, can be clinico-radiologically indistinguishable from pituitary apoplexy and should be especially considered in the differential diagnosis of patients with known primary neoplastic disease. In view of similar patho-physiological mechanism, sellar metastasis with apoplexy should be managed in a similar manner as pituitary apoplexy.
Case report
InTRoduCTIon Sellar metastasis is relatively uncommon with reported incidence varying between 1% to 8% of cancers discovered elsewhere in the body (18) . The presentation of patient with SM may be indistinguishable from pituitary adenomas (18) but SM undergoing hemorrhagic necrosis and presenting clinically as PA is very rare (1, 5, 6, 7, 9, 10, 11, 12, 14, 17) . We report a case of apoplexy in sellar metastasis from follicular carcinoma thyroid.
CASE REPoRT
A 65-year-old female with a long-standing neck swelling presented to an ophthalmologist with a history of gradually decreasing visual acuity in both eyes (right > left) for the last 10 months and recent onset ptosis of the right eye. Her visual acuity was 6/36 in right eye and 6/24 in the left eye.
The patient had bi-temporal field defects with partial III nerve palsy on the right side and pallor of the nasal half of bilateral optic discs. MRI showed a sellar mass with suprasellar extension as well as extension into bilateral cavernous sinuses (engulfment of B/L carotid arteries, right > left) ( Figure 1 ). The patient was referred to the neurosurgery department where examination confirmed the above findings. Due to irregularity of the thyroid swelling, FNAC was requested which showed follicular carcinoma of thyroid. Tc-99m MDP and Iodine 131 scan showed increased tracer uptake in the region of the thyroid gland, sella turcica and basisphenoid thus confirming the diagnosis of follicular carcinoma of thyroid with SM. Her hormonal profile (thyroid functions, cortisol and prolactin) was normal. The patient underwent total thyroidectomy. Histopathology confirmed follicular carcinoma of thyroid. In view of her age and metastatic disease, high-dose radioiodine
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ablation was planned for the SM by the department of nuclear medicine. Two weeks after thyroidectomy, she again presented with sudden onset of severe headache associated with total loss of vision in both eyes. Examination revealed loss of perception of light in both eye and bilateral ophthalmoplegia. Bilateral pupillary reflexes were absent. CT scan showed blood density within the sellar mass. A diagnosis of SM with apoplexy was made (Figure 2A, B) . The patient was given high doses of steroids and was taken to surgery for trans-sphenoidal decompression. On opening the sellar dura, 
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dark-coloured thick blood was seen flowing out which was collected for examination. After removal of the blood, the sella appeared empty but the descent of diaphragma sella was not observed under the microscope. In view of the constant trickle of blood and cavernous sinus invasion, curettage of sella was done cautiously but did not yield any tumor tissue. Histopathological examination revealed blood mixed with necrotic tissue (hemorrhagic necrosis). Postoperatively the headache disappeared and the ophthalmoplegia improved in both eyes. Improvement of vision was not so impressive with the right eye showing perception of light and the left eye showing hand movements only. The postoperative hormonal profile showed hypothyroidism and hypocortisolism. Appropriate hormone replacements were started and she was referred back to nuclear medicine for radio-ablation of metastasis. High dose radio-ablation with radioiodine was carried out. Post radio-ablation Tc-99m MDP scan revealed systemic progression of metastatic disease to appendicular skeleton as well as the base of skull. Finally one year after surgical decompression she succumbed to metastatic disease.
dISCuSSIon
Pituitary apoplexy a rare but life-threatening condition resulting from rapid enlargement of a pituitary adenoma because of hemorrhage or infarction (2, 16) . Apoplexy is of sudden onset and may be characterized by sudden headache, visual disturbance, ophthalmoplegia, pituitary hypofunction, physical collapse, altered sensorium and death (16) . Our patient conforms to the above definition of clinical apoplexy.
Although PA typically occurs in pituitary macroadenoma, it has been described in the normal pituitary gland, craniopharyngioma and lymphocytic hypophysitis (2, 16) . A syndrome clinically similar to PA in a known case of SM is very rare and only ten cases have been reported in literature up to September 2009 (Table I) . One case of PA in SM, thought to be a corticotrophic pituitary adenoma was discovered at autopsy (5) . PA in SM was the first presentation of primary disease in two cases (5,9) whereas the rest of the cases were known patients of malignant diseases (1, 6, 7, 10, 11, 12, 14, 17 Trans-sphenoidal decompression.
Blood + necrotic tissue.
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Our patient had marginal improvement in vision but a definite improvement in ophthalmoplegia following decompression.
In view of the similarity in the pathophysiological mechanism, SM with apoplexy should be treated in a manner similar to PA and we recommend the guidelines proposed by Semple et al (16) . According to the authors, emergency surgery is required in case of deteriorating vision, sudden onset of blindness, or diminished level of consciousness. Early surgery within the first week is recommended in case of visual impairment.
In case the patient is seen some time after ictus (days or weeks) and shows a stable or improving ophthalmoplegia, conservative treatment is justified.
Another issue which requires attention is the management of residual metastatic disease once the patient has undergone treatment for apoplexy. Although there are no established therapeutic guidelines, the SM should be treated as systemic disease with chemotherapy, radiotherapy or more recently with gamma knife (18) .
ConCLuSIon
Apoplexy in SM although very rare can be indistinguishable clinically and radiologically from PA and should be considered especially in the differential diagnosis of patients with known primary neoplastic disease. In view of similar pathophysiological mechanism, SM with apoplexy should be managed in a similar way as PA with high dose steroids and early trans-sphenoidal decompression. Although there are no established therapeutic guidelines, the residual sellar metastatic disease should be treated as systemic disease.
Abbreviations. PA: pituitary apoplexy, SM: sellar metastasis, SAH: subarachnoid hemorrhage, TRH: thyrotropin-release hormone, TSH: thyroid-stimulating hormone, MRI: magnetic resonance imaging.
from renal cell carcinoma is the commonest form of SM to undergo apoplexy in the cases reported in literature (3/9). Our case was a 65-year-old female who had a known SM from follicular thyroid carcinoma and was being treated for the same and presented with a clinico-radiological picture indistinguishable from PA. Biopsy showed blood mixed with necrotic tissue but Iodine 131 and Tc-99 MDP scan proved beyond doubt that sellar metastasis was from the thyroid gland. To the best of our knowledge it is the first case of metastatic follicular thyroid carcinoma presenting as PA.
The differential diagnosis of PA includes aneurismal SAH, meningitis, stroke, migraine, optic neuritis, cavernous sinus thrombosis, encephalitis, pituitary abscess, sinusitis and myocardial infarction (4, 16) . Apoplexy in a case of SM may be the first presentation of primary disease (9) . In view of the cases reported in literature, SM should also be included in the differential diagnosis of PA especially in known cases of primary neoplastic disorders.
Precipitants of PA can be divided into four categories; a) reduced blood flow with rapid growth of tumor outstripping its own blood supply, b) acute increase in blood flow, c) endocrine stimulation of the pituitary gland and d) the anti-coagulated state (3). Intrinsic vasculopathy in pituitary tumors rendering them more susceptible to infarction and hemorrhage explains the vascular event in apoplexy (4) . In light of the above mechanisms we put forward the following hypothesis for the occurrence of apoplexy in our patient. Following thyroidectomy, the decrease in serum levels of T3 and T4 hormone would have resulted in offsetting the strong negative feedback on TRH and TSH resulting in their increased blood levels leading to stimulation of SM. In the presence of vasculopathy, it might have resulted in hemorrhagic necrosis of SM. In view of our case report, recombinant TRH should be used cautiously in functional thyroid tumors with SM for radio-ablation.
MRI is the investigation of choice for sellar pathology (2, 15, 16, 18) . In case the patient is very sick or MRI is unavailable, CT scan is helpful and can show blood density within the sellar mass (13,16). Hyperdense blood within the sellar mass on CT scan confirmed the diagnosis of apoplexy in our patient.
Immediate institution of high dose corticosteroid therapy and trans-sphenoidal decompression are the main stay treatment for PA (2, 4, 16) but there is some disagreement with regard to surgical treatment (4, 8, 16) . Some authors have reported better results with early decompression (2, 16) . Others (8) concluded that patients with visual impairment or diminished level of consciousness would benefit from surgery whereas conservative treatment was as effective as surgery in patients with ophthalmoplegia. All the cases of SM with apoplexy reported in the literature underwent transsphenoidal decompression (1, 6, 7, 9, 10, 11, 12, 14, 17) . In terms of visual outcome, they reported mixed results with one report showing complete reversal of unilateral visual loss (10).
